sizofiran has been researched along with Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, J | 1 |
| Hashimoto, J; Kakuta, H; Kano, Y | 3 |
4 other study(ies) available for sizofiran and Lymphoma
| Article | Year |
|---|---|
[Immunotherapy of malignant lymphoma with interleukin-2 and sizofiran--a basic study on EL-4 lymphoma-transplanted mice].
Topics: Animals; Female; Immunotherapy; Interleukin-2; Lymphoma; Mice; Mice, Inbred C57BL; Recombinant Proteins; Sizofiran; T-Lymphocytes | 1994 |
Augmentation of antitumor effect by combined administration with interleukin-2 and sizofiran, a single glucan, on murine EL-4 lymphoma.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cytotoxicity, Immunologic; Flow Cytometry; Humans; Interleukin-2; Lymphoma; Mice; Mice, Inbred C57BL; Recombinant Proteins; Sizofiran; Survival Rate | 1996 |
Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; G(M1) Ganglioside; Immunohistochemistry; Interleukin-2; Liver; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Recombinant Proteins; Sizofiran; Spleen | 1996 |
Augmentation of the antitumor effect of adoptive immunotherapy by in vivo sensitization of EL-4 lymphoma and pre-treatment with sizofiran.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Humans; Immunotherapy, Adoptive; Killer Cells, Lymphokine-Activated; Liver Neoplasms, Experimental; Lymphoma; Mice; Mice, Inbred C57BL; Mitomycin; Sizofiran; Spleen; Splenic Neoplasms | 1998 |